Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01872442 |
|
Recruitment Status :
Completed
First Posted : June 7, 2013
Last Update Posted : February 10, 2020
|
Sponsor:
Poitiers University Hospital
Information provided by (Responsible Party):
Poitiers University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 31, 2018 |
| Actual Study Completion Date : | October 31, 2018 |